236 related articles for article (PubMed ID: 36078119)
1. Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging.
Le HT; Staelens M; Lazzari D; Chan G; Tuszyński JA
Cells; 2022 Aug; 11(17):. PubMed ID: 36078119
[TBL] [Abstract][Full Text] [Related]
2. A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.
Li X; Liu K; Xing L; Rubinsky B
Radiol Oncol; 2023 Sep; 57(3):279-291. PubMed ID: 37665740
[TBL] [Abstract][Full Text] [Related]
3. Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment.
Carrieri FA; Smack C; Siddiqui I; Kleinberg LR; Tran PT
Front Oncol; 2020; 10():575992. PubMed ID: 33215030
[TBL] [Abstract][Full Text] [Related]
4. Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.
Mumblat H; Martinez-Conde A; Braten O; Munster M; Dor-On E; Schneiderman RS; Porat Y; Voloshin T; Davidi S; Blatt R; Shteingauz A; Tempel-Brami C; Zeevi E; Lajterer C; Shmueli Y; Danilov S; Haber A; Giladi M; Weinberg U; Kinzel A; Palti Y
Lung Cancer; 2021 Oct; 160():99-110. PubMed ID: 34482104
[TBL] [Abstract][Full Text] [Related]
5. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
6. Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells.
Giladi M; Schneiderman RS; Voloshin T; Porat Y; Munster M; Blat R; Sherbo S; Bomzon Z; Urman N; Itzhaki A; Cahal S; Shteingauz A; Chaudhry A; Kirson ED; Weinberg U; Palti Y
Sci Rep; 2015 Dec; 5():18046. PubMed ID: 26658786
[TBL] [Abstract][Full Text] [Related]
7. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma.
Sarkari A; Korenfeld S; Deniz K; Ladner K; Wong P; Padmanabhan S; Vogel RI; Sherer LA; Courtemanche N; Steer C; Wainer-Katsir K; Lou E
Elife; 2023 Nov; 12():. PubMed ID: 37955637
[TBL] [Abstract][Full Text] [Related]
8. Thymidine decreases the DNA damage and apoptosis caused by tumor-treating fields in cancer cell lines.
Jeong H; Jo Y; Yoon M; Hong S
Genes Genomics; 2021 Sep; 43(9):995-1001. PubMed ID: 33950471
[TBL] [Abstract][Full Text] [Related]
9. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.
Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D
Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030
[TBL] [Abstract][Full Text] [Related]
10. Alternating Electric Fields (TTFields) Activate Ca
Neuhaus E; Zirjacks L; Ganser K; Klumpp L; Schüler U; Zips D; Eckert F; Huber SM
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669316
[TBL] [Abstract][Full Text] [Related]
11. Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
Voloshin T; Schneiderman RS; Volodin A; Shamir RR; Kaynan N; Zeevi E; Koren L; Klein-Goldberg A; Paz R; Giladi M; Bomzon Z; Weinberg U; Palti Y
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080774
[TBL] [Abstract][Full Text] [Related]
12. An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields.
Tuszynski JA; Wenger C; Friesen DE; Preto J
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27845746
[TBL] [Abstract][Full Text] [Related]
13. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
14. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
[TBL] [Abstract][Full Text] [Related]
15. Tumour treating fields in a combinational therapeutic approach.
Branter J; Basu S; Smith S
Oncotarget; 2018 Nov; 9(93):36631-36644. PubMed ID: 30564303
[TBL] [Abstract][Full Text] [Related]
16. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
17. Tumor treating fields: narrative review of a promising treatment modality for cancer.
Kutuk T; Atak E; La Rosa A; Kotecha R; Mehta MP; Chuong MD
Chin Clin Oncol; 2023 Dec; 12(6):64. PubMed ID: 37953242
[TBL] [Abstract][Full Text] [Related]
18. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
Tanzhu G; Chen L; Xiao G; Shi W; Peng H; Chen D; Zhou R
Cell Death Discov; 2022 Oct; 8(1):416. PubMed ID: 36220835
[TBL] [Abstract][Full Text] [Related]
19.
Blatt R; Davidi S; Munster M; Shteingauz A; Cahal S; Zeidan A; Marciano T; Bomzon Z; Haber A; Giladi M; Weinberg U; Kinzel A; Palti Y
Front Oncol; 2021; 11():670809. PubMed ID: 34249709
[TBL] [Abstract][Full Text] [Related]
20. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma.
Swanson KD; Lok E; Wong ET
Curr Neurol Neurosci Rep; 2016 Jan; 16(1):8. PubMed ID: 26739692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
